328 related articles for article (PubMed ID: 17897004)
21. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.
Gray JA; Roth BL
Brain Res Bull; 2001 Nov; 56(5):441-51. PubMed ID: 11750789
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5-HT-7 receptor ligands on memory and cognition.
Zareifopoulos N; Papatheodoropoulos C
Neurobiol Learn Mem; 2016 Dec; 136():204-209. PubMed ID: 27780766
[TBL] [Abstract][Full Text] [Related]
23. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of serotonin 5-HT
Thirumaran SL; Lepailleur A; Rochais C
Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
[TBL] [Abstract][Full Text] [Related]
25. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
[TBL] [Abstract][Full Text] [Related]
26. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Pranzatelli MR
Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
[TBL] [Abstract][Full Text] [Related]
27. Ligand induced conformational states of the 5-HT(1A) receptor.
Sylte I; Bronowska A; Dahl SG
Eur J Pharmacol; 2001 Mar; 416(1-2):33-41. PubMed ID: 11282110
[TBL] [Abstract][Full Text] [Related]
28. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed.
Xie Z; Lee SP; O'Dowd BF; George SR
FEBS Lett; 1999 Jul; 456(1):63-7. PubMed ID: 10452531
[TBL] [Abstract][Full Text] [Related]
29. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
30. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
31. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
32. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
33. Pharmacophore models for metabotropic 5-HT receptor ligands.
Bojarski AJ
Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
[TBL] [Abstract][Full Text] [Related]
34. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
Amelin AV; Skoromets AA; Ignatov IuD
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
[No Abstract] [Full Text] [Related]
35. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT
Tempio A; Niso M; Laera L; Trisolini L; Favia M; Ciranna L; Marzulli D; Petrosillo G; Pierri CL; Lacivita E; Leopoldo M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348850
[TBL] [Abstract][Full Text] [Related]
37. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Doménech T; Beleta J; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
[TBL] [Abstract][Full Text] [Related]
39. Serotonin and the GI tract.
Hasler WL
Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
[TBL] [Abstract][Full Text] [Related]
40. Modulation of agonist and antagonist interactions in serotonin 1A receptors by alcohols.
Harikumar KG; Chattopadhyay A
FEBS Lett; 1998 Oct; 438(1-2):96-100. PubMed ID: 9821966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
